EnteroMedics Inc. (NASDAQ:ETRM) is UP over 100%


EnteroMedics Inc. (NASDAQ:ETRM) is UP over 100%

Post by vilhiem » Tue Jun 22, 2010 12:39 pm

EnteroMedics Inc. (Public, NASDAQ:ETRM) is now trading @ $0.60 or UP over 100% for the day. I mentioned them here earlier today when they were @ $0.44 and have since gone up 36%. They have a 52-week range of 0.27 - 5.58 (with the 0.27 being hit just yesterday)

Here's the news:

EnteroMedics Announces Updated Data From EMPOWER Study
http://www.marketwatch.com/story/data-f ... _news_stmp

ST. PAUL, MN, Jun 22, 2010 (MARKETWIRE via COMTEX) -- EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced that updated clinical results from the Company's VBLOC-DM2 ENABLE (DM2) study will be presented on June 26, 2010 at 11:30 AM PT at the 27th Annual Meeting of the American Society of Metabolic and Bariatric Surgeons (ASMBS), being held June 21-26 in Las Vegas, NV. The Company also announced today updated data from its EMPOWER(TM) study in obesity.

"The DM2 study is noteworthy in that we see significant, sustained improvements in glycemic control and blood pressure as well as clinically meaningful weight loss, without a compromise in patient safety," said James Toouli, M.D., professor of surgery at Flinders University in Adelaide, Australia, and one of the study's investigators. "These results are comparable to changes seen with other procedures and do not appear to be dependent only on reduction of the glycemic load."

"The study's glycemic control data are particularly promising, as published research indicates an HbA1c level below 7 percent is associated with fewer microvascular complications and reduced cardiovascular disease," Dr. Toouli added, noting the National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2002. "I look forward to further investigating the potential of VBLOC Therapy in the treatment of obesity and its related co-morbidities."


Who is online

Users browsing this forum: No registered users and 4 guests